Celldex Therapeutics
CLDX
#5290
Rank
HK$8.14 B
Marketcap
HK$122.67
Share price
-7.99%
Change (1 day)
-60.40%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.66. In 2022 the company made an earnings per share (EPS) of -HK$18.58 a decrease over its 2021 EPS that were of -HK$12.75.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.811.25%
2022-HK$18.5845.73%
2021-HK$12.75-23.36%
2020-HK$16.64-41.05%
2019-HK$28.22-76.95%
2018-HK$122.4445.03%
2017-HK$84.43-42.54%
2016-HK$146.93-3.82%
2015-HK$152.76-0.76%
2014-HK$153.9229.41%
2013-HK$118.940%
2012-HK$118.94-9.73%
2011-HK$131.771312.5%
2010-HK$9.33-95.79%
2009-HK$221.38-49.64%
2008-HK$439.62-82.64%
2007-HK$2,533-44.98%
2006-HK$4,6041270.83%
2005-HK$335.8433.33%
2004-HK$251.88-10%
2003-HK$279.86-16.67%
2002-HK$335.84-38.46%
2001-HK$545.73-4.88%
2000-HK$573.72-81.66%
1999-HK$3,127-87.2%
1998-HK$24,424206.39%
1997-HK$7,97113.02%
1996-HK$7,053

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$31.17 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.61-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$93.91 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.00-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.46-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.21-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$4.43-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA